IRadimed Corporation

IRMD· NASDAQ· Health Care· Health Care Equipment & Services

$82.74+0.19%

2026-09-17

Financials

Valuation Metrics

IRadimed Corporation's Market Cap is $1.06B. At end of 2025 it was $1.24B. Ranked #2445 of 3,121 in US market (top 78%), #994 of 1,463 on NASDAQ (top 68%), #153 of 205 in Health Care Equipment & Services (top 75%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$1.06B	US#2,445/3,121 Sec#153/205
Revenue	$86M	US#2,728/3,121 Sec#188/205
Net Income	$23M	US#2,080/3,121 Sec#104/205
Total Assets	$115M	US#3,056/3,121 Sec#199/205
Net Assets	$102M	US#2,808/3,121 Sec#179/205
Value
P/E	45.88x	US#1,883/3,121 Sec#95/205
P/B	10.39x	US#2,627/3,121 Sec#168/205
PEG	3.95x	US#1,179/3,121 Sec#63/205
P/S	12.25x	US#2,734/3,121 Sec#186/205
EV/EBITDA	32.10x	US#2,243/3,121 Sec#123/205
FCF Yield	2.36%	US#1,970/3,121 Sec#117/205
Profitability
ROE	22.66%	US#480/3,121 Sec#25/205
ROA	20.05%	US#107/3,121 Sec#5/205
Op. Margin	31.92%	US#470/3,121 Sec#7/205
Revenue Growth	11.21%	US#1,168/3,121 Sec#78/205
Earnings Growth	11.60%	US#1,048/3,121 Sec#56/205
Financial Health
Debt Ratio	13.00%	US#147/3,121 Sec#9/205
Total Debt	$0.00	US—/3,121 Sec—/205
FCF	$25M	US#2,152/3,121 Sec#129/205
Cash	$59M	US#2,514/3,121 Sec#159/205
Current Ratio	9.46x	US#275/3,121 Sec#11/205
Net Debt/EBITDA	-1.90x	US#179/3,121 Sec#15/205
Dividend
Div. Yield	1.50%	US#1,121/3,121 Sec#19/205
Div. Growth	9.96%	US#518/3,121 Sec#17/205
Performance
1Y Return	16.93%	US#1,256/3,121 Sec#95/205
1M Return	-5.49%	US#1,809/3,121 Sec#144/205
From 52W High	-23.32%	US#1,707/3,121 Sec#121/205
1Y MDD	-22.14%	US#859/3,121 Sec#19/205
Trading
Volume	90,346 shares	US#2,935/3,121 Sec#197/205
Trading Value	$8M	US#2,494/3,121 Sec#161/205
Per Share
EPS	$1.80	US#1,400/3,121 Sec#71/205
BPS	$7.96	US#2,010/3,121 Sec#118/205